Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Michelle Wirtz, Interim Chief Financial Officer, are scheduled to participate in the Canaccord Genuity 42nd Annual Growth Conference on August 8-11, 2022. Management will be available for investor one-on-ones on Wednesday, August 10, 2022.

About Electromed, Inc.

Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992. Further information about the Company can be found at www.smartvest.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220719006102/en/

Michelle Wirtz, Interim Chief Financial Officer (952) 758-9299 investorrelations@electromed.com Mike Cavanaugh, Investor Relations ICR Westwicke (617) 877-9641 mike.cavanaugh@westwicke.com

Electromed (AMEX:ELMD)
Historical Stock Chart
From Aug 2024 to Sep 2024